T1	PROC 46 60	Ensayo clínico
#1	AnnotatorNotes T1	C0008976; Clinical Trials; Research Activity
T2	LIVB 64 73	pacientes
#2	AnnotatorNotes T2	C0030705; Patients; Patient or Disabled Group
T3	DISO 78 84	Sepsis
#3	AnnotatorNotes T3	C0243026; Sepsis; Disease or Syndrome
T4	PROC 90 121	evaluar la seguridad y eficacia
T5	CHEM 158 167	Linezolid
#4	AnnotatorNotes T5	C0663241; linezolid; Organic Chemical · Pharmacologic Substance
T6	PROC 207 274	Ensayo clínico pragmático, multicéntrico, aleatorizado y controlado
T7	LIVB 278 287	pacientes
#5	AnnotatorNotes T7	C0030705; Patients; Patient or Disabled Group
T8	DISO 292 298	Sepsis
#6	AnnotatorNotes T8	C0243026; Sepsis; Disease or Syndrome
T9	PROC 304 335	evaluar la seguridad y eficacia
T10	CHEM 369 371	Pk
#7	AnnotatorNotes T10	C0034348; Pyruvate Kinase; Amino Acid, Peptide, or Protein · Enzyme
T11	PROC 372 374	Pd
T12	CHEM 407 416	LINezolid
#8	AnnotatorNotes T12	C0663241; linezolid; Organic Chemical · Pharmacologic Substance
T13	DISO 440 446	Sepsis
#9	AnnotatorNotes T13	C0243026; Sepsis; Disease or Syndrome
T14	LIVB 476 493	Pacientes adultos
T15	Age 486 493	adultos
T16	Age 495 508	18 años o más
T17	PROC 512 523	tratamiento
#10	AnnotatorNotes T17	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T18	CHEM 528 537	linezolid
#11	AnnotatorNotes T18	C0663241; linezolid; Organic Chemical · Pharmacologic Substance
T19	PROC 543 554	Diagnóstico
#12	AnnotatorNotes T19	C0011900; Diagnosis; Diagnostic Procedure
T20	DISO 558 564	sepsis
#13	AnnotatorNotes T20	C0243026; Sepsis; Disease or Syndrome
T21	PROC 573 577	SOFA
T22	DISO 602 629	disfunción orgánica crónica
T23	Duration 622 629	crónica
T24	PROC 707 730	tratamiento antibiótico
T25	CHEM 735 744	linezolid
#14	AnnotatorNotes T25	C0663241; linezolid; Organic Chemical · Pharmacologic Substance
T26	PROC 751 767	práctica clínica
T27	PROC 807 835	Interrupción del tratamiento
T28	PROC 856 873	muestra de sangre
T29	LIVB 878 923	Mujeres embarazadas o en periodo de lactancia
T30	DISO 929 936	Alergia
#15	AnnotatorNotes T30	C0020517; Hypersensitivity; Pathologic Function
T31	DISO 939 956	hipersensibilidad
#16	AnnotatorNotes T31	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T32	CHEM 968 977	linezolid
#17	AnnotatorNotes T32	C0663241; linezolid; Organic Chemical · Pharmacologic Substance
T33	LIVB 987 996	pacientes
#18	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	Negated 987 996	pacientes
T35	Neg_cue 1003 1012	excluidos
T36	PROC 1043 1065	ensayo de intervención
